Retraction of hydroxychloroquine paper exposes faults in COVID-era clinical researchA now-retracted observational study of hydroxychloroquine had a ripple effect on randomized control trials in Canada and around the world, just as other, non-fraudulent, observational studies have done. Use of antihypertensive drugs generates pressure-packed debate in COVID-19 eraResearchers have been trying to understand a possible link between blood pressure medications and COVID-19 Tips for managing patients with asthma or COPD during the COVID-19 pandemic Canadian Thoracic Society provides guidance on optimizing asthma and COPD management throughout the COVID-19 pandemic Can antibody tests tell us who is immune to COVID-19? It’s not yet clear whether antibodies in the blood of patients who have been infected with SARS-CoV-2 indicate immunity Health Canada examines link between ibuprofen and 'flesh-eating disease' in children with chickenpox Finds no association between use of nonprescription ibuprofen-containing products and the occurrence of necrotizing fasciitis Website provides advice on COVID-19 and childhood diabetes all in one place Good quality Information was previously hard to access for families New national guidance on continuity of immunization programs during the COVID-19 pandemic Delays in immunization increase the likelihood of vaccine-preventable disease outbreaks Hydroxychloroquine appears to increase risk of mortality when used to treat COVID-19 The largest study on the drug to date found that not only is there no benefit in treating COVID-19, but also a very consistent risk of harm COVID-19 and post-infection immunity: what’s known and unknown Research on post-infection immunity boosted by Health Canada’s approval of first serological test for IgG antibodies against SARS-CoV-2 Pediatric multisystem inflammatory syndrome possibly linked to COVID-19 UK and US issue health alerts regarding Kawasaki disease shock syndrome-like illness in children and teenagers First Previous 58 59 60 61 62 Next Last
